Drupal.behaviors.print = function(context) {window.print();window.close();}>
Inform Genomics Developing SNP Test to Predict Side Effects, Help MDs Choose among Chemo Regimens
October 10, 2012
Inform Genomics Developing SNP Test to Predict Side Effects, Help MDs Choose among Chemo Regimens
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Startup Twistnostics Developing Rapid Microarray Platform for PGx and Infectious Disease Assays
March 26, 2013 / BioArray News
20/20 GeneSystems Developing mTOR Pathway Test to Predict Herceptin Response in HER2-Positive Patients
September 19, 2012 / Pharmacogenomics Reporter
Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
August 21, 2012 / BioArray News
GenMark Hopes to Expand Dx Menu This Year with Broader HCV Assay, KRAS Test, Respiratory Virus Panel
April 3, 2012 / BioArray News
GeneKey Sees Breadth of Cancer Genome Advisory Service as Differentiator in Rapidly Growing Market
December 21, 2011 / Pharmacogenomics Reporter